ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

Figure 2

ADAMTSL4 was correlated with existing biomarkers in pGBM (WHO grade IV). ADAMTSL4 was significantly increased in IDH1/2 wild-type pGBMs both in the CGGA and TCGA database (a). ADAMTSL4 was significantly increased in MGMT unmethylated group in the TCGA database, but no significance was tested in the CGGA database () (b). ns, , , and indicate , , , and , respectively.

(a)

(b)